Evidence map›Paper›PMID 38808842›Full record

ArticleRevista peruana de medicina experimental y salud publica2024

Factors associated with the consumption of medicinal plants for the prevention of COVID-19 in peruvian population: a cross-sectional study.

Fabricio Ccami-Bernal, Cristhian Rojas-Miliano, David R Soriano-Moreno, Daniel Fernández-Guzmán, Carlos Quispe-Vicuña, Enrique A Hernández-Bustamante, Elvira G Zamora-Huaringa, Wendy Nieto-Gutiérrez

Abstract read
In one paragraph

Article in Revista peruana de medicina experimental y salud publica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fabricio Ccami-BernalUniversidad Nacional de San Agustín de Arequipa, Arequipa, Perú.ORCID http://orcid.org/0000-0003-3172-2113
Cristhian Rojas-MilianoUniversidad Nacional del Centro del Perú (UNCP), Huancayo, Perú.ORCID http://orcid.org/0000-0002-3364-4940
David R Soriano-MorenoUnidad de Investigación Clínica y Epidemiológica, Escuela de Medicina, Universidad Peruana Unión, Lima, Perú.ORCID http://orcid.org/0000-0002-3690-0014
Daniel Fernández-GuzmánCarrera de Medicina Humana, Universidad Científica del Sur, Lima, Perú.ORCID http://orcid.org/0000-0002-9441-1067
Carlos Quispe-VicuñaSociedad Científica San Fernando, Universidad Nacional Mayor de San Marcos, Lima, Perú.ORCID http://orcid.org/0000-0003-0076-0985
Enrique A Hernández-BustamanteSociedad Científica de Estudiantes de Medicina de la Universidad Nacional de Trujillo, Trujillo, Perú.ORCID http://orcid.org/0000-0002-1974-5200
Elvira G Zamora-HuaringaFacultad de Medicina Humana, Universidad Ricardo Palma, Lima, Perú.ORCID http://orcid.org/0000-0003-4208-0582
Wendy Nieto-GutiérrezUnidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Perú.ORCID http://orcid.org/0000-0001-8012-1520

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

OBJECTIVES.: Motivation for the study. No study conclusively recommends the use of medicinal plants to treat COVID-19 symptoms, and their indiscriminate use may present health risks. Main findings. Sixty percent of participants consumed medicinal plants to prevent COVID-19. This was particularly true for those living in the Peruvian highlands and individuals with family members diagnosed or deceased from COVID-19, who perceive a higher risk of infection and use medications or chlorine dioxide as preventive measures. Implications. Communication strategies emphasizing validated preventive practices and educating about the risks of consuming medicinal plants should be tailored to the predominant characteristics of the consumer. Determine the factors associated with the consumption of medicinal plants as a preventive measure against COVID-19 in the Peruvian population. MATERIALS AND METHODS.: A population over 18 years of age, living in Peru and without a history of COVID-19 disease, was evaluated. The factors associated with the consumption of medicinal plants were evaluated using a Poisson regression model with robust variances. RESULTS.: Of the 3231 participants included, 84.6% were young adults (18-29 years old), 62.7% were women, and 59.7% consumed a medicinal plant to prevent COVID-19 infection. The factors associated with the consumption of medicinal plants to prevent COVID-19 infection were residing in the Peruvian highlands, having had a family member diagnosed with COVID-19, having had a family member die from COVID-19, considering their family to be at increased risk of infection, having used medications or chlorine dioxide to prevent COVID-19, having medical information as the main source of information about COVID-19, thinking that medicinal plants are effective in preventing COVID-19 disease, or not being informed about their effectiveness. CONCLUSION.: Sixty percent of the participants reported having consumed a medicinal plant to prevent COVID-19. Authorities must apply communication strategies about the implications of consuming medicinal plants, prioritizing population groups with higher consumption patterns.

Indexed as

COVID-19Plants, MedicinalAdolescentAdultAgedCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPeruPhytotherapyYoung Adult

Identifiers

PMID38808842
PMCPMC11149759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.